BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8630907)

  • 1. Bulky centroblastic non-Hodgkin's lymphoma of the cranium vault mimicking brain involvement managed with chemotherapy: a case report.
    Landys KE; Berg GE; Torgerson JS; Klingenstierna HA; Ridell BS; Johansson BR
    Cancer; 1995 Oct; 76(7):1261-7. PubMed ID: 8630907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
    Sonneveld P; de Ridder M; van der Lelie H; Nieuwenhuis K; Schouten H; Mulder A; van Reijswoud I; Hop W; Lowenberg B
    J Clin Oncol; 1995 Oct; 13(10):2530-9. PubMed ID: 7595704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complete regression of cardiac non-Hodgkin's lymphoma after 23 months with chemotherapy].
    Pettelot G; Gibelin P; Blanc P; Hoffman P; Fuzibet JG; Ferrari E; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1996 Mar; 89(3):379-81. PubMed ID: 8734193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma.
    Economopoulos T; Fountzilas G; Pavlidis N; Kalantzis D; Papageorgiou E; Christodoulou C; Hamilos G; Nicolaides C; Dimopoulos M
    Hematol J; 2003; 4(2):110-5. PubMed ID: 12750729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
    Bergeron C; Le Moine P; Le Prise-Fleury E; Jouan H; Tass P; Darcel F; Chatel M; Edan C; Patte C; Faivre J
    Med Pediatr Oncol; 1993; 21(4):307-10. PubMed ID: 8469228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-COMM-B induction chemotherapy in intermediate and high grade non-Hodgkin's lymphoma.
    Phillips JK; Sherlaw-Johnson C; Davies JM; Clough JV; Parry H; Nash JR; Cawley JC
    Leuk Lymphoma; 1995 Jun; 18(1-2):137-43. PubMed ID: 8580816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience.
    Vose JM; Weisenburger DD; Lynch JC; Bierman PJ; Chan JC; Bast M; Aoun P; Bociek G; Greiner T; Armitage JO;
    Leuk Lymphoma; 2002 Apr; 43(4):799-804. PubMed ID: 12153167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
    Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal primary lymphoma of the cranial vault in a non-immunocompromised adolescent.
    Khalid M; Siddiqui MA; Qaseem SM; Ahmad M; Khalid S
    JBR-BTR; 2010; 93(6):296-8. PubMed ID: 21381526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant non-Hodgkin's lymphoma of the cranial vault: a case report.
    Curty B; Kernan J; Favre J
    Br J Neurosurg; 1997 Oct; 11(5):433-6. PubMed ID: 9474277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale of therapy with mitoxantrone in non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Co-operative Study Group, (NHLCSG) Italy.
    Chisesi T
    Leuk Lymphoma; 1993 Jan; 9(1-2):63-9. PubMed ID: 8477203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary non-Hodgkin lymphoma of the cranial vault.
    Naama O; Gazzaz M; Boucetta M; Elmoustarchid B
    Rev Neurol (Paris); 2017 Dec; 173(10):668-670. PubMed ID: 28629635
    [No Abstract]   [Full Text] [Related]  

  • 15. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
    Sugimoto T; Matano S; Nishijima H; Kakuta K; Inamura K; Okamura T; Munemoto S; Satoh S
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen.
    Sonneveld P; Michiels JJ
    Br J Cancer; 1990 Jul; 62(1):105-8. PubMed ID: 2390469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B?
    Mazza P; Bocchia M; Zanchini R; Gherlinzoni F; Zinzani PL; Pileri S; Tura S
    Haematologica; 1991; 76(1):47-52. PubMed ID: 1711505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse large B cell lymphoma of the cranial vault: two case reports.
    Tashiro R; Kanamori M; Suzuki H; Utsunomiya A; Meguro K; Uenohara H; Tominaga T
    Brain Tumor Pathol; 2015 Oct; 32(4):275-80. PubMed ID: 26177806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
    Dhaliwal HS; Rohatiner AZ; Gregory W; Richards MA; Johnson PW; Whelan JS; Gallagher CJ; Matthews J; Ganesan TS; Barnett MJ
    Br J Cancer; 1993 Oct; 68(4):767-74. PubMed ID: 8398705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
    Tomita N; Kodama F; Sakai R; Koharasawa H; Hattori M; Taguchi J; Fujita H; Tanabe J; Fujisawa S; Fukawa H; Harano H; Kanamori H; Miyashita H; Matsuzaki M; Ogawa K; Motomura S; Maruta A; Ishigatsubo Y
    Leuk Lymphoma; 2000 Jul; 38(3-4):335-43. PubMed ID: 10830740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.